Grupp S, Maude S, Baruchel A, et al. Tisagenlecleucel appears effective and safe in pediatric and young adult patients with relapsed/refractory acute lymphoblastic leukemia with high-risk cytogenetic abnormalities. 24th Congress of EHA, abstract S1618.
Allo-HSCT voor patiënten met AML: behandeling op maat
okt 2017 | Leukemie, Stamceltransplantatie